tbuckley/cabot-search huggingface dataset:
Dementia, Frailty and Triage in a Pandemic
Authors: Dominic J. C. Wilkinson
Journal: The American Journal of Bioethics (2021)

This article refers to:Frailty Triage: Is Rationing Intensive Medical Treatment on the Grounds of Frailty Ethical?A Critique of the Use of the Clinical Frailty Scale in TriageThe Other Side of Triage: When Access to Intensive Care Measures May Do More Harm than GoodThe Complex Relationship between Disability Discrimination and Frailty ScoresThe Frailty of Disability: A Controversial Triage CriterionFrailty, an Imperfect ICU Rationing CriterionTriage Criteria: Medically, Ethically or Socially Defined?Triage: Medical Details and Words MatterDoing Justice to Patients with Dementia in ICU Triage
In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y
Authors: Ali A. Taleb, Robert G. Badgett
Journal: Annals of Internal Medicine (2021)

ACP Journal ClubOctober 2021In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 yAli A. Taleb, MD, Robert G. Badgett, MDAli A. Taleb, MDUniversity of Kansas School of Medicine, Wichita, Kansas, USA (A.A.T., R.G.B.)Search for more papers by this author, Robert G. Badgett, MDUniversity of Kansas School of Medicine, Wichita, Kansas, USA (A.A.T., R.G.B.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJ202110190-115 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationMenzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384:1800-9. https://pubmed.ncbi.nlm.nih.gov/33979488Clinical Impact RatingsGIM/FP/GP: Pulmonology: References1. Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55:1900588. [PMID: 31558662] Google Scholar2. Corren J, Parnes JR, Wang L, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377:936-46. [PMID: 28877011] Google Scholar3. openMetaAnalysis Contributors. Asthma immunomodulation. Updated 16 Jul 2021. Accessed at http://openmetaanalysis.github.io/asthma/ on 19 Aug 2021. Google Scholar Author, Article, and Disclosure InformationAffiliations: University of Kansas School of Medicine, Wichita, Kansas, USA (A.A.T., R.G.B.)Disclosures: The commentators have reported no disclosures of interest. The forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-7321.This article was published at Annals.org on 5 October 2021. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe Effects of a Transgelin-2 Agonist Administered at Different Times in a Mouse Model of Airway HyperresponsivenessEmerging treatments for chronic urticaria October 2021Volume 174, Issue 10Page: JC115 ePublished: 5 October 2021 Issue Published: October 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
361P Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Authors: A.V.A. Beige, F. Ghiringhelli, J. Vincent, J. Lecuelle, C. Truntzer, W. Farah, F. Borsotti, I. Mazilu, S.M. Ilie
Journal: Annals of Oncology (2021)
UK’s share of the global carbon budget will be used up in 3.3 years
Authors: Ian R Campbell
Journal: BMJ (2021)

How urgent is an “emergency?”1 After the 2019 street protests, many national and local administrations declared a climate emergency but have since failed to implement the “rapid and far reaching transitions” recommended by the Intergovernmental Panel on Climate Change (IPCC) 2018 report2 that sparked the protests.

The urgency of the climate emergency can be quantified by the carbon budget—how much more carbon dioxide (CO2 …
LBA50 A randomized phase III study comparing cisplatin-pemetrexed (cis-pem) with carboplatin (C)-paclitaxel (P)-bevacizumab (B) in chemotherapy naïve patients (pts) with advanced KRAS mutated non-small cell lung cancer (NSCLC): NVALT22
Authors: A-M.C. Dingemans, S. Ernst, W. Mellema, S. Burgers, J. Staal-van den Brekel, L.E.L. Hendriks, T.J.N. Hiltermann, N. van Walree, K. Maas, M. Youssef-ElSoud, B. Biesma, V. van Noord, E.F.F. Smit, J.A. De Langen
Journal: Annals of Oncology (2021)
2O Penpulimab, an IgG1 anti-PD-1 antibody with Fc-engineering to eliminate effector functions and with unique epitope and binding properties
Authors: B. Li, Z. Huang, X. Pang, T. Zhong, C. Jin, N. Chen, S. Ma, X. He, D. Xia, X. Jin, Z. Wang, Y. Xia
Journal: Annals of Oncology (2021)
1507MO Selection of quality indicators (QI) by non-hospital professionals for onco-hematology care pathway
Authors: M. di Palma, M. Ferrua, A. Fourcade, M. Chirrane, B. Clairaz, J. De La Cruz, F. Loiseau, B. Ortolan, R. Pêcheux, R. Schwaller, J. Sicard, S. Siegrist, P. Sontag, J. Stoklosa, G. Tasseel, C. Trentini, None F. veron, L. Verone, C. VogensthaL, E. Minvielle
Journal: Annals of Oncology (2021)
1223P Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm+) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
Authors: S. Popat, H.A. Jung, S. Yup Lee, M.J. Hochmair, S.H. Lee, C. Escriu, M.K. Lee, M.R. Migliorino, Y.C. Lee, N. Girard, H. Daoud, A. Märten, S. Miura
Journal: Annals of Oncology (2021)
1404P Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial
Authors: J. Wang, T. Wu, Y-G. Hong, S-X. Luo, N. Li, Y-Z. Guo, Y-F. Cheng
Journal: Annals of Oncology (2021)
1595P Acceptance of COVID-19 vaccination among cancer patients in an Irish cancer centre
Authors: W.J. Mullally, C. Flynn, P. Carr, M.J. Kennedy, D. O'Donnell, M. McCarthy, S.P. Alken, K. Cadoo, S. Sukor, M. Lowery, D.J. Gallagher, C. Grant, F. Kelleher, S. Cuffe
Journal: Annals of Oncology (2021)
癌光療法のための生体適合性標的特異的ナノキャリアとしての表面修飾による自然発生ナノチューブ【JST・京大機械翻訳】
Authors: Li Luo-Yuan, Zhou Yi-Ming, Gao Rong-Yao, Liu Xiao-Chen, Du Hui-Hui, Zhang Jia-Ling, Ai Xi-Cheng, Zhang Jian-Ping, Fu Li-Min, H Skibsted Leif
Journal: Biomaterials (2019)
1760MO Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort
Authors: K. Hodroj, P-E. Heudel, M. Fonnesu, A. Karabajakian, V.K. Attignon, O. Tredan, T. Filleron, I.J. Garberis, M. Jimenez, F. André, T. Bachelot
Journal: Annals of Oncology (2021)
932P IMbrave150: Exploratory efficacy and safety results in patients with hepatocellular carcinoma without macrovascular invasion (MVI) or extrahepatic spread (EHS) treated with atezolizumab (atezo) + bevacizumab (bev) or sorafenib (sor)
Authors: M. Kudo, R.S. Finn, P.R. Galle, A. Zhu, M.P. Ducreux, A-L. Cheng, W. Verret, V.E. Gaillard, A. Nicholas, R. Lencioni
Journal: Annals of Oncology (2021)
1056P Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study
Authors: I. Marquez-Rodas, M.A. Berciano Guerrero, E. Muñoz Couselo, J.L. Manzano, G. Crespo Herrero, A. Soria, P. Cerezuela, T. Puertolas Hernandez, A. Berrocal, M. Majem Tarruella, L. Bellido Hernández, E. Espinosa, A. Garcia Castano, J. Medina Martínez, L.A. Fernandez Morales, C. Aguado de la Rosa, L. Gutierrez Sanz, R. Lopez Castro, P. Ayala de Miguel, S. Martin Algarra
Journal: Annals of Oncology (2021)
P-117 Survival outcomes following systemic chemotherapy in stage IVA/B high-grade mucinous appendiceal cancer after unsuccessful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Authors: E. Baron, V. Gushchin, M. King, A. Nikiforchin, F. Lopez-Ramirez, M. Sittig, A. Sardi, P. Ledakis
Journal: Annals of Oncology (2021)
Endoscopic four-branched stent-in-stent deployment of self-expandable metal stents in malignant hilar biliary obstruction
Authors: Junichi Kaneko, Takanori Yamada, Kyoichi Fukita, Atsushi Tsuji, Masafumi Nishino, Yurimi Takahashi, Yuzo Sasada
Journal: Endoscopy (2021)

Malignant hilar biliary obstruction often requires multiple stents for biliary drainage [1] [2]. However, deploying three or more self-expandable metal stents (SEMSs) is technically challenging [3]. The recently launched, novel uncovered SEMS with slim delivery system (Niti-S Large Cell SR Slim delivery; TaeWoong Medical, Seoul, South Korea) may be combined with a 6-mm balloon catheter (REN biliary dilation catheter; KANEKA, Osaka, Japan) to facilitate the deployment of multiple SEMSs [4]. Here, we report a successful endoscopic four-branched deployment of SEMSs using the stent-in-stent (SIS) method.
1218P Characterization of GI toxicities and their impact on efficacy in patients (pts) with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) treated with mobocertinib (TAK-788) who previously received platinum chemotherapy
Authors: D. Nguyen, S.S. Ramalingam, A. Spira, G.J. Riely, T.M. Kim, J.C-H. Yang, Z. Piotrowska, M.R. Garcia Campelo, E. Felip, L. Bazhenova, S. Jin, C. Griffin, P.M. Diderichsen, N. Gupta, V. Bunn, J. Lin, E.N. Churchill, M. Mehta, C. Zhou, P.A. Janne
Journal: Annals of Oncology (2021)
1550P A post hoc analysis of the EPAZ trial: The prognostic role of geriatric variables in elderly soft tissue sarcoma (STS) patients
Authors: R.W. Hamacher, X. Liu, M.K. Schuler, L. Hentschel, P. Schöffski, H-G. Kopp, S. Bauer, B. Kasper, L.H. Lindner, J-M. Chemnitz, M. Crysandt, A. Stein, B. Steffen, S. Richter, G. Egerer, P. Ivanyi, A. Kunitz, V. Grünwald
Journal: Annals of Oncology (2021)
1785P Tumor irradiation may improve the sensitivity of liquid biopsy: The analysis of RAS/RAF mutations in plasma obtained from radiotherapy-treated rectal cancer patients
Authors: E.N. Imyanitov, T.A. Laidus, F. Moiseyenko, S. Belukhin, E. Stepanova, M. Zakharova, V. Chernobrivtseva, I. Aliev, T. Sharabura, V.M. Moiseyenko, S. Aleksakhina, A. Martianov, G.A. Yanus, A. Togo, E.S. Kuligina
Journal: Annals of Oncology (2021)
Abnormal Electrocardiograms After Diarrhea and Syncope in the Emergency Department
Authors: Guoliang Li, Xingpu Quan, Yang Yan
Journal: JAMA Internal Medicine (2021)

This case report presents the electrocardiographic findings for an 80-year-old man who presented to the emergency department with syncope 1 hour prior and severe vomiting and diarrhea over the past 3 days.
LBA43 GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT)
Authors: Y-L. Wu, Q. Zhou, M. Chen, O. Jiang, D. Hu, Q. Lin, G. Wu, J. Cui, J. Chang, Y. Cheng, C. Huang, A. Liu, N. Cui, J. Wang, Q. Wang, M. Qin, R. Zhang, J. Yang
Journal: Annals of Oncology (2021)
1607P Trends in cancer imaging by indication, care setting, and hospital type during the COVID-19 pandemic and recovery
Authors: O. Zattra, A. Fraga, N. Lu, M.S. Gee, R. Liu, M.H. Lev, J. Brink, S. Saini, M. Lang, M.D. Succi
Journal: Annals of Oncology (2021)
650TiP PARADIGM: Plasma analysis for response assessment and to direct the management of metastatic prostate cancer (mPCa)
Authors: A.K. Jayaram, A. Reid, G. Wheeler, C. Alifrangis, J. O'Dwyer, R. Jones, C. Pezaro, E. Pintus, J. Staffurth, S. Crabb, H. Sidhu, K. Smith, S. Brock, S. Rodwell, A. Wingate, L. Zakka, M. Chiwewe, H. Cartwright, L. White, G. Attard
Journal: Annals of Oncology (2021)
Abstract 5781: Evaluation of Global and Regional Right Ventricular Systolic Function in Patient Prosthesis Mismatch after Mitral Valve Replacement using Velocity Vector Imaging
Authors: Aylin Tugcu, Yelda Tayyareci, Ozlem Yildirimturk, Saide Aytekin
Journal: Circulation (2008)

The aim of this study was to compare right ventricular (RV) global and regional systolic function in patients with and without patient prosthesis mismatch (PPM) after isolated mitral valve replacement (MVR) using Velocity Vector Imaging (VVI) method. The PPM group consisted of 20 patients that underwent isolated MVR with an indexed effective orifice area (EOA) ≤ 1.2 cm 2 /m 2 determined by continuity equation and indexed for body surface area. The non-PPM group consisted of 20 patients that also underwent isolated MVR with an indexed EOA &gt; 1.2cm 2 /m 2 . Echocardiographic images in apical planes were analyzed for RV volumes, ejection fractions, myocardial velocity, strain and strain rate at the basal, mid and apical segments of RV free wall and ventricular septum using VVI. The demographic and preoperative data were similar between PPM and non-PPM groups. Evidence of PA hypertension defined as systolic PA pressure &gt; 40 mmHg was present in 50% of patients in PPM group, whereas none of the patients in non-PPM group had PA hypertension. RV volumes were significantly increased, and RV ejection fraction, peak systolic myocardial velocities, strain and strain rates were significantly impaired in patients with PPM compared to non-PPM group (p&lt;0.001 for all). Indexed EOA correlated strongly with myocardial velocities, strain and strain rates in all segments of the RV (p&lt;0.05 for all). Multivariate stepwise regression analysis demonstrated that indexed EOA and systolic PA pressure were the independent determinants of basal free wall peak systolic strain (β=0.547, p&lt;0.001 and β=−0.304, p=0.033 respectively) and strain rate (β=0.497, p=0.001 and β=−0.332, p = 0.026 respectively). Using receiver-operating characteristics analysis cut-off values for basal free wall peak systolic strain and strain rate in determining patients with indexed EOA ≤ 1.2 cm 2 /m 2 were −25.62 % (sensitivity 85%, specificity 95%) and −1.87 1/s (sensitivity 95%, specificity 95%) respectively. PPM after MVR is associated with RV global and regional RV dysfunction. Two-dimensional echocardiography has some limitations in evaluating RV function due to its complex geometry. VVI is a feasible modality in assessment of RV global and regional RV function.
1332P A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Authors: S. Takeuchi, S. Sugawara, S. Teramukai, R. Noro, K. Fujikawa, T. Hirose, S. Atagi, S. Minami, S. Iida, H. Kuraishi, T. Aiba, M. Kawahara, Y. Minegishi, M. Matsumoto, M. Seike, A. Gemma, K. Kubota
Journal: Annals of Oncology (2021)
제 7 차 춘계학술대회 초록집 : 포스터 발표 ; 라미부딘 장기투여 중 발생한 B 형 간염 바이러스 YMDD 영역의 유전자변이
Authors: 이종훈, 신우원, 안현숙, 성명식, 정동엽, 강기태, 김병희, 노명환, 한상영, 최석렬
Journal: Clinical and Molecular Hepatology (2001)
473P A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
Authors: A. Kawazoe, S. Iwasa, K. Shitara, T. Koyama, Y. Ueda, S. Nagao, T. Kimura, I. Suzuki, S. Dayal, T. Tamai, A. Nayudu, N. Yamamoto
Journal: Annals of Oncology (2021)
Comparison of Publication of Pediatric Probiotic vs Antibiotic Trials Registered on ClinicalTrials.gov
Authors: Madison Riddell, Kaden Lam, Anna Funk, Nidhi Lodha, Diane L. Lorenzetti, Stephen B. Freedman
Journal: JAMA Network Open (2021)

<h3>Importance</h3> The published evidence in support of probiotic use is conflicting, which may be a result of selective publication of probiotic trials. <h3>Objectives</h3> To compare the proportion of registered trials that evaluate pediatric probiotics vs those that evaluate antibiotics that are published and to identify study-related factors associated with publication status. <h3>Design, Setting, and Participants</h3> This cross-sectional study evaluated eligible trials registered in ClinicalTrials.gov, an online clinical trials registry, from July 1, 2005, to June 30, 2016. Eligible studies included participants younger than 18 years, evaluated a probiotic or 1 of the 5 most commonly prescribed antibiotics in children and adolescents, and randomized study participants. All searches were updated and finalized as of September 9, 2020. <h3>Exposures</h3> Probiotic or antibiotic. <h3>Main Outcomes and Measures</h3> The primary outcome was study publication status. In addition, exposure status (probiotic vs antibiotic), trial result, and funding source were assessed for independent association with publication status. Whether study design elements, publication journal impact factor, and the interval from study completion to publication differed by exposure status were also evaluated. <h3>Results</h3> A total of 401 unique trials (265 probiotic and 136 antibiotic) met eligibility criteria. A greater proportion of antibiotic compared with probiotic studies were published (83 [61.0%] vs 119 [44.9%]; difference, 16.1% [95% CI, 5.8%-25.9%]). After adjustment for funding source, blinding, and purpose, studies evaluating an antibiotic were more likely to be published (odds ratio, 2.1 [95% CI, 1.3-3.4]). No other covariates included in the model were independently associated with publication status. Antibiotic trials, compared with probiotic trials, were more likely to have a therapeutic purpose (114 [83.8%] vs 117 [44.2%]; difference, 39.6% [95% CI, 31.1%-48.3%]) and to be multicenter (46 [33.8%] vs 46 [17.4%]; difference, 16.5% [95% CI, 7.5%-25.7%]). The median impact factor of the journals in which the studies were published was higher for the antibiotic trials (7.2 [IQR, 2.8-20.5] vs 3.0 [IQR, 2.3-4.2];<i>P</i> &lt; .001). The median number of days to publication did not differ between the probiotic and antibiotic trials (683 [IQR, 441-1036] vs 801 [IQR, 550-1183];<i>P</i> = .24). <h3>Conclusions and Relevance</h3> The findings of this cross-sectional study suggest that probiotic studies are less likely to be published than antibiotic trials. No other study characteristics were associated with publication status. This finding raises concerns regarding the results of meta-analyses of probiotic trials.
902P Clinical profile and treatment outcomes of patients treated with induction chemotherapy for locally advanced carcinoma oral tongue: A retrospective analysis
Authors: P. Govind, C.T. Kainickal, R.R. Kumar, M. Rafi, L. Attokaran Lonappan, A. Prakasan, P. George, R. Kunnambath
Journal: Annals of Oncology (2021)
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Authors: G. Mazzaschi, R. Scandino, G. Milanese, C. Pavone, B. Maurizio, M. Silva, R. Ledda, R. Minari, F. Trentini, S. Buti, P. Bordi, A. Leonetti, F. Quaini, N. Sverzellati, A. Romanel, M. Tiseo
Journal: Annals of Oncology (2021)
Carcinomatosis Encephalitis Secondary to Neuroendocrine Transformation of Prostate Cancer
Authors: Alexandria Ellen Melendez-Zaidi, Alexander Ou, Gregory N. Fuller
Journal: JAMA Neurology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
Endoscopic treatment of a liver hydatid cyst with biliary rupture
Authors: Mohamed Borahma, Yousra Jebari, Fatima Zahra Chabib, Nawal Lagdali, Imane Benelbarhdadi, Fatima Zahra Ajana
Journal: Endoscopy (2021)

Hydatid disease is a parasitic infection caused by the larva of Echinococcus granulosus, for which the liver represents the most common site of involvement [1]. One of the most serious complications of hepatic hydatid cyst disease is rupture of the cyst into the biliary tree, leading to jaundice and cholangitis. Recently endoscopic retrograde cholangiopancreatography (ERCP) has emerged as an alternative method of providing therapy for patients with biliary hydatid disease [2].
1544P Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations
Authors: T.W-W. Chen, R.C-J. Chang, A. Le Cesne, Y-C. Hsieh, A. Italiano, Y-W. Yang, N. Penel, W-C. Lee, E. Bompas, T. Valentin, P. Anract, N. Firmin, F. Duffaud, K.A. Chan, J-Y. Blay
Journal: Annals of Oncology (2021)
1508MO Rationalizing the use of off-label drugs (OLD) within a special medication (ME) program for cancer patients (pt): The Catalan Institute of Oncology (ICO) prognostic score (ICO MEscore)
Authors: L. Notario Rincon, C. Hierro, A. Esteve, S. Fontanals, A. González, E. Loureiro, C. Sun, M. Margelí, T. Moran, A. Font, J.L. Manzano, C. Balaña, V. Quiroga, N. Quer, C. Ibañez, J. Martínez-Benavides, J. Brunet, A. Clopes, R. Mesia
Journal: Annals of Oncology (2021)
801P Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma
Authors: E. Colomba, J. Alexandre, G. Le Teuff, D. Coupez, C. Genestie, I.L. Ray-Coquard, P.E. Brachet, C. Sajous, S. De Percin, M. Fabbro, N. Delanoy, F. Joly, P. Pautier, J-S. Frenel, A. Leary
Journal: Annals of Oncology (2021)
420P A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)
Authors: K. Ding, Y. Liu, J. Du, Y. Zhu, D. Xu, J. Li, X. Liao, J. He, J. Wang, Z. Liu, L. Sun, Q. Xiao, J. Wang, H. Cao, Y. Cai, C. Cai, Z. Jin, Y. Yuan
Journal: Annals of Oncology (2021)
88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study
Authors: S. Joris, H. Denys, M. Martin, D. t'Kint de Roodenbeke, F. Duhoux, G. Berchem, K. Punie, A. Bols, J. Mebis, J-L. Canon, L. Decoster, J. De Grève
Journal: Annals of Oncology (2021)
LBA42 COAST: An open-label, randomised, phase II platform study of durvalumab alone or in combination with novel agents in patients with locally advanced, unresectable, stage III NSCLC
Authors: A. Martinez-Marti, M. Majem, F. Barlesi, E. Carcereny Costa, Q. Chu, I. Monnet, A. Sanchez, S. Dahkil, D.R. Camidge, P. He, Y. Soo-Hoo, Z. Cooper, R. Kumar, J. Bothos, C. Aggarwal, R.S. Herbst
Journal: Annals of Oncology (2021)
1747P Total versus subtotal thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications
Authors: L. Tchabashvili, F. Mulita, E. Liolis, F. Seretis, C. Seretis, M. Vailas, K-M. Plachouri, K. Panagopoulos, N. Kritikos, I. Maroulis
Journal: Annals of Oncology (2021)